EUBIO revenue for the last year amounted to 69.20 B KRW, the most of which — 69.37 B KRW — came from its highest performing source at the moment, Biological Products and Medical Supplies, the year earlier bringing 55.47 B KRW. The greatest contribution to the revenue figure was made by Africa — last year it brought EUBIO 56.42 B KRW, and the year before that — 29.92 B KRW.